BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31439240)

  • 1. The enhanced T
    Han X; Sun M; Wang M; Fan R; Chen D; Xie L; Liu A
    Eur J Radiol; 2019 Sep; 118():187-193. PubMed ID: 31439240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.
    Xiao F; Zhang L; Yang S; Peng K; Hua T; Tang G
    J Ovarian Res; 2022 Jan; 15(1):13. PubMed ID: 35062992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of normalized apparent diffusion coefficients in differentiating between borderline and malignant epithelial ovarian tumors.
    Lu J; Pi S; Ma FH; Zhao SH; Li HM; Cai SL; Qiang JW
    Eur J Radiol; 2019 Sep; 118():44-50. PubMed ID: 31439257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression.
    Li HM; Zhao SH; Qiang JW; Zhang GF; Feng F; Ma FH; Li YA; Gu WY
    J Magn Reson Imaging; 2017 Nov; 46(5):1499-1506. PubMed ID: 28295854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of contrast-enhanced dual-energy spectral CT for differentiating borderline from malignant epithelial ovarian tumours.
    Han X; Li B; Sun M; Li J; Li Y; Liu A
    Clin Radiol; 2021 Aug; 76(8):585-592. PubMed ID: 34059294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation.
    Zhao SH; Qiang JW; Zhang GF; Ma FH; Cai SQ; Li HM; Wang L
    Eur Radiol; 2014 Sep; 24(9):2292-9. PubMed ID: 24871335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI features and score for differentiating borderline from malignant epithelial ovarian tumors.
    Li YA; Qiang JW; Ma FH; Li HM; Zhao SH
    Eur J Radiol; 2018 Jan; 98():136-142. PubMed ID: 29279152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of enhanced T2 star-weighted angiography (ESWAN) and R2* values to distinguish ovarian cysts due to endometriosis from other causes.
    Li Y; Song QW; Sun MY; Wang HQ; Wang S; Wei Q; Liu JH; Tian SF; Tong ZB; Liu AL
    Abdom Imaging; 2015 Aug; 40(6):1733-41. PubMed ID: 25504223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial Ovarian Tumors.
    Ye R; Weng S; Li Y; Yan C; Chen J; Zhu Y; Wen L
    Korean J Radiol; 2021 Jan; 22(1):106-117. PubMed ID: 32932563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors.
    He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J
    J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of ESWAN in diagnosis and differential diagnosis of prostate cancer: Preliminary study.
    Xin JY; Gao SS; Liu JG; Sun CF; Han Y; Sun XH; Wang XZ; Wang B
    Magn Reson Imaging; 2017 Dec; 44():26-31. PubMed ID: 28782677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric MRI for differentiation of borderline ovarian tumors from stage I malignant epithelial ovarian tumors using multivariate logistic regression analysis.
    Denewar FA; Takeuchi M; Urano M; Kamishima Y; Kawai T; Takahashi N; Takeuchi M; Kobayashi S; Honda J; Shibamoto Y
    Eur J Radiol; 2017 Jun; 91():116-123. PubMed ID: 28629557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between borderline ovarian tumors and carcinomas using semi-automated histogram analysis of diffusion-weighted imaging: focusing on solid components.
    Mimura R; Kato F; Tha KK; Kudo K; Konno Y; Oyama-Manabe N; Kato T; Watari H; Sakuragi N; Shirato H
    Jpn J Radiol; 2016 Mar; 34(3):229-37. PubMed ID: 26798066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
    Li HM; Feng F; Qiang JW; Zhang GF; Zhao SH; Ma FH; Li YA; Gu WY
    Abdom Radiol (NY); 2018 Nov; 43(11):3132-3141. PubMed ID: 29556691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serum CA-125 concentration data assists in evaluating CT imaging information when used to differentiate borderline ovarian tumor from malignant epithelial ovarian tumors.
    Shin JE; Choi HJ; Kim MH; Cho KS
    Korean J Radiol; 2011; 12(4):456-62. PubMed ID: 21852906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour.
    Kurata Y; Kido A; Moribata Y; Kameyama K; Himoto Y; Minamiguchi S; Konishi I; Togashi K
    Eur Radiol; 2017 Apr; 27(4):1695-1703. PubMed ID: 27553934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors.
    Huang K; Xu S; Wang J; Ge L; Xu J; Jia X
    J Ovarian Res; 2023 Feb; 16(1):37. PubMed ID: 36759870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple instance convolutional neural network with modality-based attention and contextual multi-instance learning pooling layer for effective differentiation between borderline and malignant epithelial ovarian tumors.
    Jian J; Xia W; Zhang R; Zhao X; Zhang J; Wu X; Li Y; Qiang J; Gao X
    Artif Intell Med; 2021 Nov; 121():102194. PubMed ID: 34763809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
    Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging.
    Kurata Y; Kido A; Moribata Y; Kameyama K; Minamiguchi S; Konishi I; Togashi K
    Magn Reson Med Sci; 2018 Jul; 17(3):211-217. PubMed ID: 28993546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.